According to Hongxun Technology's announcement, the cumulative deviation value of the closing price increase of the company's stock exceeded 20% for two consecutive trading days on January 7 and January 8, 2026, which is an abnormal fluctuation. After self-inspection, the company's internal and external business environment has not changed, and no important information should have been disclosed. The market classifies it as a “nuclear fusion concept stock,” and its Italian subsidiary only provides components, accounts for a small share of business revenue, and has limited impact on short-term results. From January to September 2025, the company's revenue was 608.8041 million yuan, down 5.65% year on year; net profit was 32.0491 million yuan, down 35.18% year on year. Remind investors to be aware of the risks.

According to Hongxun Technology's announcement, the cumulative deviation value of the closing price increase of the company's stock exceeded 20% for two consecutive trading days on January 7 and January 8, 2026, which is an abnormal fluctuation. After self-inspection, the company's internal and external business environment has not changed, and no important information should have been disclosed. The market classifies it as a “nuclear fusion concept stock,” and its Italian subsidiary only provides components, accounts for a small share of business revenue, and has limited impact on short-term results. From January to September 2025, the company's revenue was 608.8041 million yuan, down 5.65% year on year; net profit was 32.0491 million yuan, down 35.18% year on year. Remind investors to be aware of the risks.